Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-4 Registration of securities (foreign)
- 3.1 Amended and Restated Memorandum and Articles of Association of Omnigenicsai, Dated As of March 16, 2024
- 4.4 Form of Assignment, Assumption and Amendment Agreement with Respect to the Warrant Agreement Between Apx Acquisition Corp. I, Omnigenicsai and Continental Stock Transfer & Trust Company
- 5.1 Legal Opinion of Ogier (Cayman) LLP
- 10.8 Reseller License Agreement Term Sheet, Dated As of August 11, 2024 Between Omnigenicsai and Multiplai
- 10.9 Commercialization Agreement, Dated January 3, 2017, Between Centro De Diagnostico Medico De Alta Complejidad S.a. and Heritas Sau
- 10.10 First Amendment to Commercialization Agreement, Dated October 1, 2018, Between Centro De Diagnostico Medico De Alta Complejidad S.a. and Heritas Sau
- 10.11 Services Agreement, Dated March 11, 2024, Between Meyer Lab S.a. and Heritas Sau
- 10.12 First Amendment to the Services Agreement, Dated November 1, 2024, Between Meyer Lab S.a. and Heritas Sau
- 21.1 List of Subsidiaries of Omnigenicsai Corp
- 23.1 Consent of Price Waterhouse & Co. S.R.L.
- 23.2 Consent of Marcum LLP
- 99.2 Consent of Fabian Fay to Be Named As a Director
- 99.3 Consent of Natalia Zang to Be Named As a Director
- 99.4 Consent of Kyle Bransfield to Be Named As a Director
- EX-FILING FEES Calculation of Filing Fee Tables
Filing view
External links